News

Covid-19 Update

Althea is monitoring the coronavirus situation carefully and we are doing everything we can to help reduce the spread of the Covid-19 disease. We continue to supply our…

read more

UK Government announces faster access to cannabis-based medicines in watershed moment for Althea UK

Althea is pleased to advise that the UK Department of Health and Social Care and Home Office (Home Office) have announced that, following the relaxation of import…

read more

Patient Growth Continues

2019 was a fantastic year of patient growth for Althea and on the back of the unrelenting efforts from our sales team, we successfully surpassed our target of 4,000…

read more

Althea Partners with UK Scientific Drug Committee

Althea Partners with UK Scientific Drug Committee to Further Education on Medicinal Cannabis and Improve Patient Access. Article Highlights: Althea collaborates…

read more

GPs Need to Know about Medicinal Cannabis

"Doctors in the dark about medicinal cannabis" A recent article published by RACGP: to read the full article click here

read more

Australia the world’s fastest-growing medicinal cannabis market

A leading supplier of medicinal cannabis increased its Australian patient numbers by 27 per cent over a three-week period in April…

read more

Medicinal cannabis patient numbers “starting to spike” for Althea

Althea now has more staff in London than Melbourne, with expectations its expertise from Australia will bring an advantage over large…

read more

Althea granted cannabis manufacture licence by Australian Government

Althea Group Holdings Ltd’s (ASX:AGH) wholly-owned subsidiary Althea Company Pty Ltd has been granted a cannabis manufacture…

read more